Company Overview and News

2
Fitbit Cares

18h seekingalpha
Fitibit announced a new platform called Fitbit Care as a focal point for their focus on health and wellness.
FIT GRMN AAPL HUM

16
GoPro Stock Shows a Short-Term Glimmer of Hope With New Camera Intros

2018-09-25 investorplace
Action camera company GoPro (NASDAQ:GPRO) unveiled its lineup of new products on Thursday, launching just ahead of this year’s all-important holiday shopping season. GoPro stock rallied a bit because, well, at least a small faction of investors rev up their bullishness whenever the company makes any sort of move.
GPRO FB FIT SNAP

5
A Strange Week Of Record Market Highs But Good Stocks Falling

2018-09-25 seekingalpha
Growth stocks have led the market for a long time, but last week we saw many interest rate-sensitive value stocks (like insurance companies and utilities) firm up. This temporary rotation into value stocks is a bit odd, since the 10-year Treasury bond yield rose decisively above the 3% level, despite low inflation.
FIT MU WEED AAPL CGC TLRY

53
The Smartest Move Is to Sell Roku Stock Before the Correction Comes

2018-09-25 investorplace - 1
Roku (NASDAQ:ROKU) has been on a winning streak this summer. In just a few months, ROKU stock is up more than 50%. Previously, Roku had seen more sideways trading as investors and analysts considered various pros and cons affecting the company.
SONO GPRO FIT AMZN ROKU NFLX DIS

1
Fitbit's Significant Advantage Over The Apple Watch

2018-09-20 seekingalpha
Despite Apple being the first major wearables company to introduce a product that was cleared by the FDA, I remain very bullish on Fitbit.
FIT AAPL

2
Fitbit Partners With Humana, Unviels Fitbit Care Platform

2018-09-20 zacks
Fitbit, Inc. (FIT - Free Report) recently expanded its partnership with Humana Inc. (HUM - Free Report) , in order to help people improve health culture and prevent chronic diseases.
FIT ADTTF AAPL HUM ATEYY

1
Fitbit (FIT) in Focus: Stock Moves 5.3% Higher

2018-09-20 zacks
Fitbit, Inc. (FIT - Free Report) was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $5.45–$6.29 in the past one-month time frame, witnessed a sharp increase yesterday.
FIT KEYS SIR HAYN LB

7
Humana (HUM) Expands Pact With Fitbit to Rein in Claim Cost

2018-09-20 zacks
Health insurer Humana Inc. (HUM - Free Report) has extended its partnership (since 2013) with Fitbit, Inc. (FIT - Free Report) , the leading global wearables brand. The arrangement between the two companies will aid Humana’s members in the employer group segment to adopt and implement healthy behaviors, which in turn would prevent and manage chronic health conditions. Fitbit’s health coaching solution named Fitbit Care, will help more than 5 million Humana members access ways to make necessary lifestyle changes in order to better manage chronic and complex diseases such as diabetes and heart disease.
ATHTF FIT CI ANTM LB HUM ANTX

32
3 Companies Left Out of the Latest Trump Tariffs

2018-09-19 zacks
The trade war between the U.S. and China continues to escalate, with Beijing set to impose tariffs on $60 billion in U.S. imports in response to the Trump administrations’ new set of tariffs on $200 billion in Chinese imports. Despite the mounting pressure on companies in the world’s two largest economies, some firms and their products appear to be safe.
FB FIT SPWR UNP NFLX GOOGL AAPL MSFT GM INTC

1
Wall Street Shrugs Off Trade Fears: 6 Large-Cap ETF Picks

2018-09-19 zacks
The Wall Street has shown immense strength, shrugging of escalating trade war concerns between the United States and China. All the three major large-cap indices were up at least 0.5% on Sep 18 with Dow Jones logging in the best day in about three weeks. This suggests strong complacency in the stock market backed by booming economy and strong corporate earnings. A slew of upbeat economic data indicates a healthier economy.
FNDX FIT UNP AAPL DIA VYM SPYV

5
Stock Market News For Sep 19, 2018

2018-09-19 zacks
Wall Street closed sharply higher on Tuesday reversing the previous day’s losses as investors shrugged off trade war jitters. Elimination of nearly 300 important items from the list of Chinese products which were targeted by the Trump administration in the last round of tariffs along with a measured response on the part of China lifted confidence of market participants. Consequently, a broad-based market rally enabled all here major stock indexes to finish in positive territory.
FIT CATR CAT BOE AAPL BA

4
Holiday Retail Sales Likely to Rise YoY: 5 Picks

2018-09-19 zacks
The holiday season is approaching and retailers are set to hire seasonal workers. Per Deloitte’s annual forecast for the holiday season, retail sales could top $1.10 trillion this year. With record low unemployment, higher wages and strong consumer confidence, an increasing number of Americans are willing to spend more.
MOV FIT SUMR TLYS AAPL ZUMZ MOVAA BOOT

1
Fitbit announces new Care platform for health plans, expands Humana partnership

2018-09-19 marketwatch
Fitbit Inc. on Wednesday announced its new Fitbit Care platform, part of the company’s broader efforts to entice more health-care players and generate recurring revenue.
FIT HUM

22
The Zacks Analyst Blog Highlights: Apple, Fitbit, Cisco Systems, Qualcomm and Micron Technology

2018-09-19 zacks
Chicago, IL – September 19, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Apple, Inc. (AAPL - Free Report) , Fitbit, Inc. (FIT - Free Report) , Cisco Systems, Inc. (CSCO - Free Report) , Qualcomm, Inc. (QCOM - Free Report) and Micron Technology, Inc.
RYAM FIT ESE ON CVTI UNFI SWKS DVMT MU GTS AAPL CSCO MS QCOM INT CSCOI TSC

4
U.S. Markets Ignore Tariff Worries: 5 Top-Ranked Picks

2018-09-19 zacks
Wall Street shrugged off early losses on Sep 18 to close in the green as investors chose to ignore trade tensions. Stocks moved north after the latest tariffs from the United States and China were less harmful than expected.
FIT DSW CBPX USY AAPL UFPT RCII UIS

FIT : Fitbit Stock Research Analysis and Report

2017-10-11 - Asif

Fitbit's mission is to help people lead healthier, more active lives by empowering them with data, inspiration, and guidance to reach their goals. Fitbit is transforming the way millions of people around the world achieve their health and fitness goals. The Fitbit platform combines wearable devices with connected health solutions via software and services, including an online dashboard and mobile apps, data analytics, motivational and social tools, personalized insights, and virtual coaching through customized fitness plans and interactive workouts. Its platform helps people become more active, exercise more, sleep better, eat smarter, and manage their weight. Fitbit appeals to a large, mainstream health and fitness market by addressing these key needs with advanced technology embedded in simple-to-use products and services. The company pioneered the wearable device market starting in 2007, and since then, The company have grown into a leading global health and fitness brand. Fi...

Related Articles

DMPI: DelMar Pharmaceuticals Analysis and Research Report

19h - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

CUSIP: 33812L102